To investigate the effect of 1-year TA-65MD treatment on systemic inflammation and heart failure, reflected by expression of N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) and high‐sensitivity C‐reactive protein (hsCRP). Here, NPPB is linked to heart failure.